Publications

Everest Biotech products have been successfully used in the following papers:

Anti-ARPC4 Elvira Nikalayevich et al. (2024) Aberrant cortex contractions impact mammalian oocyte quality. Dev Cell. 2024 Apr 8;59(7):841-852.e7. PMID: 38387459.

Anti-FOXP2 (C terminus) Amber G. Cook et al. (2024) Cell division angle predicts the level of tissue mechanics that tune the amount of cerebellar folding. Development. 2024 Feb 1;151(3):dev202184. PMID: 38251865. 

Anti-HEXIM1 Salla Kyheröinen et al. (2024) Actin associates with actively elongating genes and binds directly to the Cdk9 subunit of P-TEFb. J Biol Chem. 2024 Mar;300(3):105698. PMID: 38301887.

Anti-MDH2 Michelle Noble et al. (2024) Cytosolic RNA binding of the mitochondrial TCA cycle enzyme malate dehydrogenase. RNA. 2024 Jun 17;30(7):839-853. PMID: 38609156.

Anti-Orexin Receptor 2 (aa405-419) Xiao-Yang Zhang et al. (2024) A role for the cerebellum in motor-triggered alleviation of anxiety. Neuron. 2024 Apr 3;112(7):1165-1181.e8. PMID: 38301648.

Anti-Orexin Receptor 2 Danlei Liu et al. (2024) Lateral hypothalamus orexinergic projection to the medial prefrontal cortex modulates chronic stress-induced anhedonia but not anxiety and despair. Transl Psychiatry. 2024 Mar 16;14(1):149. PMID: 38493173.

Anti-Pericentrin 1 / NUP85 Yugo Okabe et al. (2024) Antifibrotic effect of disulfiram on bleomycin-induced lung fibrosis in mice and its impact on macrophage infiltration. Sci Rep. 2024 Oct 10;14(1):23653. PMID: 39384840.

Anti-SM22 Alpha / Transgelin Caterina Bernacchioni et al. (2024) Sphingosine-1-phosphate receptor 3 is a non-hormonal target to counteract endometriosis-associated fibrosis. Fertil Steril. 2024 Apr;121(4):631-641. PMID: 38072366.

 Anti-VMAT2 / SLC18A2 James Hennegan et al. (2024) Inhibition of 7α,26-dihydroxycholesterol biosynthesis promotes midbrain dopaminergic neuron development. iScience. 2024 Jan 19; 27(1): 108670. PMID: 38155767.

Antibodies for Recent publications